STOCK TITAN

agilon health, inc. (AGL) withholds shares to cover CLO tax obligations

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

agilon health, inc. reports that Chief Legal Officer Denise Zamore had 37 shares of Common Stock withheld on 2026-08-01 to satisfy income tax withholding and remittance obligations related to net settlement of restricted stock units. This is characterized as a tax-withholding disposition and not a sale. Following this transaction, she directly holds 66,075 shares of Common Stock, including restricted stock units.

Positive

  • None.

Negative

  • None.
Insider Zamore Denise
Role Chief Legal Officer
Type Security Shares Price Value
Tax Withholding Common Stock F1, F2 37 $91.61 $3K
Holdings After Transaction: Common Stock — 66,075 shares (Direct)
Footnotes (2)
  1. F1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
  2. F2. Includes restricted stock units.
Shares withheld for taxes 37 shares Common Stock withheld to satisfy income tax obligations on 2026-08-01
Per-share value used 91.6100 per share Value applied to the 37 withheld Common Stock shares
Post-transaction holdings 66,075 shares Directly held agilon health Common Stock after withholding, including RSUs
restricted stock units financial
"in connection with the net settlement of the restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
net settlement financial
"obligations in connection with the net settlement of the restricted stock units"
income tax withholding financial
"withheld by the issuer to satisfy its income tax withholding and remittance obligations"
remittance obligations financial
"to satisfy its income tax withholding and remittance obligations in connection"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did agilon health (AGL) disclose for Denise Zamore?

agilon health, inc. disclosed that Chief Legal Officer Denise Zamore had 37 shares of Common Stock withheld to cover income tax obligations from net settlement of restricted stock units. The company notes this tax-withholding disposition does not represent a sale of shares.

How many agilon health (AGL) shares were withheld for Denise Zamore’s taxes?

The filing reports that 37 shares of agilon health, inc. Common Stock were withheld to satisfy income tax withholding and remittance obligations associated with net settlement of restricted stock units. This withholding is recorded as a disposition but is explicitly not treated as a sale.

How many agilon health (AGL) shares does Denise Zamore hold after the reported event?

After the tax-withholding disposition, Chief Legal Officer Denise Zamore directly holds 66,075 shares of agilon health, inc. Common Stock. A footnote clarifies that this post-transaction amount includes restricted stock units in addition to other directly held shares.

Was the agilon health (AGL) insider transaction a market sale of shares?

No. The filing states the 37 shares were withheld by agilon health, inc. to satisfy income tax withholding and remittance obligations from restricted stock unit settlement and “does not represent a sale.” It is categorized as a tax-withholding disposition, not an open-market sale.

What role does Denise Zamore hold at agilon health (AGL) in this Form 4 filing?

In this Form 4, Denise Zamore is identified as an officer of agilon health, inc., serving as Chief Legal Officer. The reported transaction reflects shares withheld for her tax obligations arising from the net settlement of restricted stock units granted as part of compensation.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zamore Denise

(Last)(First)(Middle)
C/O AGILON HEALTH, INC.
440 POLARIS PARKWAY, SUITE 550

(Street)
WESTERVILLE OHIO 43082

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/01/2026F37(1)D$91.6166,075(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
2. Includes restricted stock units.
Remarks:
/s/ Mimi Yang, as Attorney-in-Fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)